Bejerano, Pablo G.
HRN: 05-27-86 Sex: MalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/03/2024
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
01/03/2024
01/09/2024
IVTT
500 Mg
Q8
Intestinal Amoebiasis
Checking Final Appropriateness